Resultados da pesquisa - Shiladitya Sengupta

Refinar resultados
  1. 1
    Exploiting nanotechnology to target cancer

    Exploiting nanotechnology to target cancer Por Shiladitya Sengupta, Ram Sasisekharan

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Design Principles for Clinical Efficacy of Cancer Nanomedicine: A Look into the Basics

    Design Principles for Clinical Efficacy of Cancer Nanomedicine: A Look into the Basics Por Shiladitya Sengupta, Ashish Kulkarni

    Publicado em 2013
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  3. 3
    Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1

    Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1 Por Shiladitya Sengupta, Anil K. Mantha, Sankar Mitra, Kishor K. Bhakat

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins

    New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins Por Arijit Dutta, Chunying Yang, Shiladitya Sengupta, Sankar Mitra, Muralidhar L. Hegde

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy

    Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy Por Bart Thaçi, Christine E. Brown, Emanuela Binello, Katherine Werbaneth, Prakash Sampath, Shiladitya Sengupta

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy

    Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy Por Sudipta Basu, Rania Harfouche, Shivani Soni, Geetanjali Chimote, R. A. Mashelkar, Shiladitya Sengupta

    Publicado em 2009
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells

    Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells Por Stephanie Piecewicz, Ambarish Pandey, Bhaskar Roy, Soh Hua Xiang, Bruce R. Zetter, Shiladitya Sengupta

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Human Nonalcoholic Steatohepatitis on a Chip

    Human Nonalcoholic Steatohepatitis on a Chip Por May S. Freag, Bumseok Namgung, Maria E. Reyna Fernandez, Ermanno Gherardi, Shiladitya Sengupta, Hae Lin Jang

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor

    Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor Por Shiladitya Sengupta, Ermanno Gherardi, Lynda A. Sellers, Jeanette M. Wood, Ram Sasisekharan, Tai‐Ping D. Fan

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects

    Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects Por Hamid R. Molavian, Aaron Goldman, Colin Phipps, Mohammad Kohandel, Bradly G. Wouters, Shiladitya Sengupta, Sivabal Sivaloganathan

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

    Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition Por Aaron Goldman, Biswanath Majumder, Andrew Dhawan, Sudharshan Ravi, David Goldman, Mohammad Kohandel, Pradip K. Majumder, Shiladitya Sengupta

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson’s Disease

    Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson’s Disease Por Velmarini Vasquez, Joy Mitra, Pavana M. Hegde, Arvind Pandey, Shiladitya Sengupta, Sankar Mitra, K. S. Rao, Muralidhar L. Hegde

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype

    Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype Por Marcelo Boareto, Mohit Kumar Jolly, Aaron Goldman, Mika Pietilä, Sendurai A. Mani, Shiladitya Sengupta, Eshel Ben‐Jacob, Herbert Levine, José N. Onuchic

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

    A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer Por Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Anujan Ramesh, Prithvi Raj Pandey, Jayashree Nirgud, Harshangda Bhatnagar, Driti Ashok, Amrendra K. Ajay, Shiladitya Sengupta

    Publicado em 2018
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Organ‐on‐a‐Chip for Cancer and Immune Organs Modeling

    Organ‐on‐a‐Chip for Cancer and Immune Organs Modeling Por Wujin Sun, Zhimin Luo, Junmin Lee, Han‐Jun Kim, KangJu Lee, Peyton Tebon, Yudi Feng, Mehmet R. Dokmeci, Shiladitya Sengupta, Ali Khademhosseini

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Errata/Corrigenda
    Adic. favoritos
    Na minha lista:
  16. 16
    Human Apurinic/Apyrimidinic Endonuclease (APE1) Is Acetylated at DNA Damage Sites in Chromatin, and Acetylation Modulates Its DNA Repair Activity

    Human Apurinic/Apyrimidinic Endonuclease (APE1) Is Acetylated at DNA Damage Sites in Chromatin, and Acetylation Modulates Its DNA Repair Activity Por Shrabasti Roychoudhury, Somsubhra Nath, Heyu Song, Muralidhar L. Hegde, Larry J. Bellot, Anil K. Mantha, Shiladitya Sengupta, Sutapa Ray, Amarnath Natarajan, Kishor K. Bhakat

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence

    Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence Por Xingwu Zhou, Moyuan Qu, Peyton Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta, Wujin Sun, Ali Khademhosseini

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  18. 18
    The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome

    The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome Por Pavana M. Hegde, Arijit Dutta, Shiladitya Sengupta, Joy Mitra, Sanjay Adhikari, Alan E. Tomkinson, Guo‐Min Li, István Boldogh, Tapas K. Hazra, Sankar Mitra, Muralidhar L. Hegde

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Antibody nanoparticle conjugate–based targeted immunotherapy for non–small cell lung cancer

    Antibody nanoparticle conjugate–based targeted immunotherapy for non–small cell lung cancer Por Tanmoy Saha, Michaela Fojtů, Astha Vinay Nagar, Liya Thurakkal, Balaaji Baanupriya Srinivasan, M. Mukherjee, Astralina Sibiyon, Heena Aggarwal, Akash Samuel, Chinmayee Dash, Hae Lin Jang, Shiladitya Sengupta

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Modulating Angiogenesis

    Modulating Angiogenesis Por Shiladitya Sengupta, Sue-Anne Toh, Lynda A. Sellers, Jeremy N. Skepper, Pieter Koolwijk, H. W. Leung, Hin‐Wing Yeung, Ricky Ngok‐Shun Wong, Ram Sasisekharan, Tai‐Ping D. Fan

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: